Randomised feasibility trial of the helping families programme-modified: an intensive parenting intervention for parents affected by severe personality difficulties by Day, Crispin et al.
1Day C, et al. BMJ Open 2020;10:e033637. doi:10.1136/bmjopen-2019-033637
Open access 
Randomised feasibility trial of the 
helping families programme- modified: 
an intensive parenting intervention for 
parents affected by severe 
personality difficulties
Crispin Day   ,1,2 Jackie Briskman,1 Mike J Crawford,3 Lisa Foote,4 Lucy Harris,2 
Janet Boadu,5 Paul McCrone,5,6 Mary McMurran,7 Daniel Michelson,8 Paul Moran,9 
Liberty Mosse,1 Stephen Scott,10 Daniel Stahl,11 Paul Ramchandani,12 
Tim Weaver13
To cite: Day C, Briskman J, 
Crawford MJ, et al.  Randomised 
feasibility trial of the helping 
families programme- modified: 
an intensive parenting 
intervention for parents 
affected by severe personality 
difficulties. BMJ Open 
2020;10:e033637. doi:10.1136/
bmjopen-2019-033637
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
033637).
Received 20 August 2019
Revised 18 December 2019
Accepted 17 January 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Crispin Day;  
 crispin. 1. day@ kcl. ac. uk
Original research
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY. 
Published by BMJ.
AbstrACt
background Specialist parenting intervention could 
improve coexistent parenting and child mental health 
difficulties of parents affected by severe personality 
difficulties.
Objective Conduct a feasibility trial of Helping Families 
Programme- Modified (HFP- M), a specialist parenting 
intervention.
Design Pragmatic, mixed- methods trial, 1:1 random 
allocation, assessing feasibility, intervention acceptability 
and outcome estimates.
settings Two National Health Service health trusts and 
local authority children’s social care.
Participants Parents: (i) primary caregiver, (ii) 18 to 65 
years, (iii) severe personality difficulties, (iv) proficient 
English and (v) capacity for consent. Child: (i) 3 to 11 years, 
(ii) living with index parent and (iii) significant emotional/
behavioural difficulties.
Intervention HFP- M: 16- session home- based 
intervention using parenting and therapeutic engagement 
strategies. Usual care: standard care augmented by single 
psychoeducational parenting session.
Outcomes Primary feasibility outcome: participant 
retention rate. Secondary outcomes: (i) rates of 
recruitment, eligibility and data completion, and (ii) rates 
of intervention acceptance, completion and alliance 
(Working Alliance Inventory- Short Revised). Primary 
clinical outcome: child behaviour (Eyberg Child Behaviour 
Inventory). Secondary outcomes: child mental health 
(Concerns About My Child, Child Behaviour Checklist- 
Internalising Scale), parenting (Arnold- O’Leary Parenting 
Scale, Kansas Parental Satisfaction Scale) and parent 
mental health (Symptom- Checklist-27). Quantitative data 
were collected blind to allocation.
results Findings broadly supported non- diagnostic 
selection criterion. Of 48 participants recruited, 32 
completed post- intervention measures at mean 42 
weeks later. Participant retention exceeded a priori rate 
(HFP- M=18; Usual care=14; 66.7%, 95% CI 51.6% to 
79.6%). HFP- M was acceptable, with delivery longer than 
planned. Usual care had lower alliance rating. Child and 
parenting outcome effects detected across trial arms with 
potential HFP- M advantage (effect size range: 0.0 to 1.3).
Conclusion HFP- M is an acceptable and potentially 
effective specialist parenting intervention. A definitive trial 
is feasible, subject to consideration of recruitment and 
retention methods, intervention efficiency and comparator 
condition. Caution is required in interpretation of results 
due to reduced sample size. No serious adverse events 
reported.
trial registration number ISRCTN14573230
IntrODuCtIOn
Mental ill health is the largest cause of 
disability, with three- quarters of lifetime 
disorders starting during childhood.1 Chil-
dren of parents affected by severe personality 
difficulties are at particular risk due to the 
impact of parents’ symptoms and associated 
strengths and limitations of this study
 ► This randomised trial assessed the feasibility of a 
specialist parenting intervention for coexistent men-
tal health problems of parents affected by severe 
personality difficulties and their children.
 ► Findings provide useful evidence to support further 
evaluation of this specialist parenting intervention 
within a definitive trial, with modifications required 
to improve intervention efficiency, augmented usual 
care condition acceptability and participant enrol-
ment and retention.
 ► Caution is required in interpretation of results due to 
reduced sample size.
 ► The trial population’s complex personality difficulties 
underline the importance of effective and sensitive 
management of trial consent procedures, random 
allocation and ongoing engagement of participants, 
particularly for those allocated to the usual care 
condition.
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impairment on parenting capacity.2–4 Lack of evidence- 
based treatments, underdeveloped care pathways and 
stigma result in poorer immediate and longer- term child 
outcomes, increase intergenerational transmission of 
mental health difficulties and perpetuate social disadvan-
tage.5 6
Severe personality difficulties, including person-
ality disorders, affect over 4% of UK adults and 40% 
of mental health service users, at least one- quarter of 
whom are parents.7 8 Per annum UK treatment costs 
exceed £70 million, with wider societal costs estimated at 
£8 billion per year.9 Characterised by problematic inter-
personal relationships, emotional dysregulation and 
poor impulse control, severe personality difficulties are 
associated with insensitive and intrusive interactions with 
offspring, family hostility, inconsistent and unpredictable 
family routines that undermine affectionate, stable and 
responsive parenting required for healthy child devel-
opment.2–4 Affected parents are likely to suffer higher 
parenting stress and lower satisfaction, exacerbating 
underlying mental health difficulties.10 11
One in 10 UK children suffer mental health disorders, 
with children of parents with severe personality difficul-
ties at substantially higher risk of intergenerational trans-
mission, most commonly behavioural disorders.12 13 These 
childhood disorders are associated with academic failure, 
school exclusion, maltreatment, self- harm and gang affil-
iation, with increased life- time risk of comorbid mental 
and physical health conditions, drug misuse, offending 
and worklessness.1 12 13 Annual UK public service costs for 
severe behavioural problems are estimated at £5000 per 
child including £1400 health costs. Lifetime estimated 
costs range from £85 000 (moderate case) to £260 000 
(severe case).14 15
Concerted preventative and early intervention during 
pregnancy, infancy and childhood is warranted.16 Effec-
tive care models for co- occurring child and parental 
mental health problems are significant health policy 
and research priorities.17–19 Nevertheless, routine care is 
highly variable, generally focussed on the needs of either 
the adult or the child,17 resulting in under- identification, 
poor understanding of the interrelationship between 
child and parent difficulties and misattribution of 
parenting difficulties to adult mental health symptoms 
per se.20 Affected parents can be reluctant to engage due 
to stigma, treatment scepticism and the interpersonal 
difficulties and adverse life circumstances associated with 
personality difficulties.21
Parenting and parent factors are central to much 
effective child mental health treatment and problem 
remediation. Parenting programmes are the recom-
mended cost- effective treatment for child behaviour 
problems.22 23 However, non- specialised parenting 
programmes, not specifically designed for parents 
affected by mental health difficulties, often result in 
poorer engagement, acceptability and outcomes.24 25 
Specialist interventions for some parental mental health 
conditions, such as depression, substance misuse and 
eating disorders, have demonstrated improved outcomes 
and reduced intergenerational transmission, by up to 
40%.26 27 Specialist programmes for parents affected by 
personality difficulties are at an earlier stage of evidence 
production.
Helping Families Programme- Modified (HFP- M) 
was developed as a specialist, intensive parenting inter-
vention to address this need and service gap. It aims to 
improve immediate child and parenting outcomes with 
longer- term potential to reduce intergenerational trans-
mission and psychosocial adversity within affected fami-
lies.4 Guided by recommended frameworks, HFP- M 
development synthesised two existing evidence- based 
interventions, incorporating relevant clinical practice 
recommendations and service user consultation.22 28–33 
Consistent with other promising programmes aiming 
to improve parenting and child outcomes in high risk 
groups, HFP- M is based on a transtheoretical model of 
parenting drawing on attachment, social learning and 
cognitive- affective theories and methods.34 35 HFP- M 
does not target personality difficulties per se but aims 
to improve the ways that these characteristics affect 
parenting behaviour, emotional regulation, parent- child 
relationships and lead to adverse child outcomes.
HFP- M has three structured components:36 (i) Core 
Therapeutic Process: including partnership and goal- 
based methods to promote collaborative relational 
engagement, shared formulation, empathic parent vali-
dation and crisis management;36 (ii) Parent Groundwork: 
including emotion- focussed, cognitive, behavioural and 
interpersonal strategies to manage parental emotional 
dysregulation and hostility while relating to their chil-
dren and undertaking parenting tasks and (iii) Parenting 
Strategies: including consistent use of positive parenting 
skills, such as, praise, consequences and limit setting, 
and relational and affective parenting methods such as 
emotionally responsive, warm care- giving and reflective 
function.
Definitive trials require successful recruitment, reten-
tion and intervention acceptability.30 37–41 Participant 
retention underpins trial validity. Lower rates reduce 
power, undermine interpretation of findings and increase 
costs. HFP- M retention, and initial recruitment was 
expected to be affected by: (i) participants’ core clinical 
features, (ii) greater exposure to family stress, negative 
life events, lower levels of social support and comorbid 
mental health conditions and (iii) under- identification 
of need within routine care, negative referrer expectan-
cies, lower service engagement and attendance. These 
factors are reflected in evidence derived from 45 person-
ality disorder treatments trials reported in two systematic 
reviews indicating a median participant non- completion 
rate of 35%.37 42 Pre- feasibility trial case series findings, 
consultation with service user, clinicians and research 
ethics indicated that initial plans for trial recruitment 
based on personality disorder research diagnosis was 
unlikely to be viable for practical, participant accept-
ability and ethical reasons.21
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To be useful and effective in practice, interventions 
need to demonstrate both clinical efficacy and user 
acceptability. Acceptability refers to service user judge-
ments across four inter- related domains of intervention 
satisfaction: (i) relevance, (ii) content and procedures, 
(iii) clinician/provider characteristics and (iv) outcome 
suitability.39 40
This study reports quantitative findings from a 
randomised feasibility trial of HFP- M, based on a 
published protocol.4 The trial aimed to assess research 
and clinical feasibility of HFP- M for a target population 
with coexisting parent personality difficulties and child 
mental health difficulties with findings being used to 
inform the design of a full- scale trial.
The primary feasibility outcome was a participant reten-
tion rate of at least 65% post- intervention. Secondary 
feasibility outcomes were rates of: (i) participant iden-
tification and recruitment, (ii) data collection and (iii) 
intervention use, uptake and acceptability. Primary clin-
ical outcome was child behaviour. Secondary clinical 
outcomes included parental child concerns, child inter-
nalising difficulties, parenting behaviour, satisfaction and 
psychological well- being. The trial sought to produce 
effect sizes and variance estimates for child and parent 
outcomes necessary to power a full- scale trial.
The findings of a parallel qualitative process evalu-
ation investigating the influence of contextual factors 
on trial and intervention implementation and outcome 
generation are published elsewhere, as are the full find-
ings of preliminary intervention costs and estimates of 
cost- effectiveness.43
MethOD
Design
Mixed- method, two- arm, parallel feasibility trial with 
random allocation in a 1:1 ratio to either: (i) HFP- M, or 
(ii) Usual care.
Quantitative data were collected at pre- randomisation 
baseline (Time 1); post- intervention (Time 2), 6 months 
from baseline and follow- up (Time 3), 4 months and 10 
months from baseline.
eligibility criteria
Parent: (i) primary parental caregiver for index child, (ii) 
aged 18 to 65, (iii) experiencing severe personality diffi-
culties, assessed by self- administered Standardised Assess-
ment of Personality- Abbreviated Scale (SAPAS) score of 
≥3, the optimal cut- point for the intended sample popula-
tion,44 (iv) proficient written and spoken English and (v) 
capacity to provide informed consent.
Child: (i) aged 3 to 11, (ii) living with index parent 
and (iii) experiencing significant emotional/behavioural 
difficulties, assessed by Strengths and Difficulties Ques-
tionnaire Total Score of ≥17.45
Exclusion criteria
Parent: (i) coexisting psychosis, (ii) engagement in 
another structured parenting intervention, (iii) inpatient 
status or (iv) insufficient language/cognitive abilities.
Child: (i) pervasive developmental disorder, (ii) not 
residing with index parent or (iii) considered for/subject 
to child protection supervision.
Interventions
HFP-M intervention
Sixteen- session home- based 1:1 parenting intervention 
for parents with severe personality difficulties, including 
personality disorder. Session modules proceeded itera-
tively to (i) establish effective, validating collaborative 
partnership, (ii) develop shared understanding of severe 
parental personality difficulties’ impact on parenting, 
child functioning and family ecology, (iv) implement 
parent quick wins, parenting and child intervention 
goals, (v) use evidence- based parenting and parent self- 
care strategies to achieve agreed goals and (vi) recurrent 
review of goals and therapeutic partnership. Six trial ther-
apists received eight, 3- hour, training sessions provided by 
HFP- M programme developers and clinical experts. Trial 
therapists completed structured checklists and received 
fortnightly supervision from experienced HFP- M clini-
cians to support clinical implementation and fidelity.
Usual care
No systematised parenting pathway was typically provided 
for the participant population. To provide consistent, low 
intensity support, participants could receive an additional 
home- based one- to- one parent information and support 
session. Derived from the evidence- based Empow-
ering Parents Empowering Communities parenting 
programme,46 session content included: (i) brief explora-
tion of parenting and child needs, family support, parent 
priorities and goals, and (ii) focus on one parent priority 
topic, selected from Being Good Enough, Listening to My 
Child, Praising My Child, Taking Care of Myself, Under-
standing My Child’s Behaviour, My Child’s Emotion or 
Playing Together. The additional session was delivered by 
three trained parent practitioners, who received ongoing 
supervision to support implementation and fidelity.
Concomitant interventions
Both HFP- M and the single Usual care parent support 
session were provided in addition to existing medical, 
psychosocial and educational support and treatment 
services used by participating parents and their families. 
A joint- working protocol specified procedures for care 
coordination and information sharing between trial ther-
apists and routine services.
Measures
Participant characteristics
Descriptive data were collected on parent and child age, 
gender and ethnicity, family household composition, 
participant diagnostic status and family socioeconomic 
status. Data from EuroQol five dimension scale (EQ- 
5D),47 48 provided information about parent and child 
health and disability.
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Feasibility evaluation
Structured record sheets, completed prospectively by 
research staff and trial therapists, documented: (i) partic-
ipant identification and verbal consent, (ii) screening, 
eligibility, informed written consent, randomisation and 
reasons for non- participation, and (iii) data collection 
and missing data.
Clinical outcomes
 ► Eyberg Child Behaviour Inventory (ECBI),49 a 36- item 
questionnaire assessing intensity and number of 
disruptive behaviour problems in 2 to 16 year- olds, 
providing a comprehensive measure of child behav-
iour difficulties. Intensity Scale score of ≥131 indicates 
significant severity. Problem Scale score of ≥15 indi-
cates significant number of problems.
 ► Concerns About My Child (CAMC),46 a Visual 
Analogue Scale (0 to 100) rating three parental 
concerns about their child. Concerns nominated at 
baseline were re- rated at each time point, providing a 
sensitive, individualised index of change.
 ► Child Behaviour Checklist- Internalising Scale 
(CBCL- Int),50 a 32- item questionnaire assessing 
internalising problems in 6 to 18 year- olds, with 
an alternate 36- item version for children aged 1½ 
to 5 years. Standardised T- scores combine results 
from both versions. A score of ≥60 indicates clinical 
caseness.
 ► Arnold- O’Leary Parenting Scale (PS),51 a 30- item 
questionnaire assessing dysfunctional parental disci-
pline behaviour for children aged 2 to 16 years, which 
correlates with more time- consuming observational 
ratings. A score of ≥3.2 differentiates clinic and non- 
referred children.
 ► Kansas Parental Satisfaction Scale (KPSS),52 a 3- item 
scale providing a brief measure of parenting stress 
and satisfaction.
 ► Symptom- Checklist-27,53 a 27- item questionnaire 
assessing psychological symptoms in adults that 
provides a Global Severity Index of psychopathology.
Intervention acceptability
 ► Working Alliance Inventory- Short Revised (WAI- SR),54 
a parent completed 12- item questionnaire assessing 
therapeutic relationship quality consisting of three 
subscales: (i) Goals, measuring agreement on inter-
vention goals and outcomes, (ii) Tasks, measuring 
agreement on behaviours and thoughts underpin-
ning intervention process and (iii) Bond, measuring 
mutual trust, acceptance and confidence.
 ► Structured worksheets recorded intervention uptake, 
attendance, retention, reasons for missed sessions and 
dropout.
Health economic
 ► Client Service Receipt Inventory (CSRI),55 a schedule 
adapted to measure the use of services by caregivers 
and children.
 ► EQ- 5D- 5L and EQ- 5D- Y,47 48 a generic measure of 
health- related quality of life used to generate quality- 
adjusted life years. EQ- 5D- Y is adapted for younger 
respondents.
sample size
The primary feasibility criterion was post- intervention 
retention rate of at least 65%.37 42 A CI approach was 
used to calculate a planned sample size of n=70.56 Using 
a 95% CI for the proportion of parents who completed 
treatment and an expected completion rate of 80% 
based on previous evaluations of HFP, it was determined 
that an HFP- M intervention sample size of n=35 would 
provide a sufficiently precise estimate (95% CI 0.67 to 
0.93). A sample size of n=70 was also sufficient to obtain 
stable estimates of population variances for future power 
calculations.57
recruitment and consent procedures
Settings
Recruitment took place in two large UK National Health 
Service (NHS) health services and concomitant local 
authority children’s social care service in London (Site 1 
and 2), located in areas of high mental health morbidity.
Identification and consent
Clinical keyworkers undertook exploratory discussion 
and provided written information to potential partic-
ipants. With consent, contact details were provided to 
researchers, who provided information about study aims, 
eligibility criteria, procedures and a Participant Infor-
mation Sheet. One week later, parents were contacted 
to determine participation and obtain written informed 
consent.
Allocation and randomisation
Participants were allocated a unique, anonymised ID 
number and randomised to trial conditions between 
11 May 2016 and 29 March 2017 by Clinical Trials Unit, 
King’s College, London. Allocation was communicated 
confidentially to the trial coordinator, other researchers 
remained blind to allocation.
Data collection
Screening and assessments
Following consent, parents completed screening 
measures, and, when eligible, baseline measures in a 
standard sequence. Any parent discomfort was addressed 
sensitively and supportively. Persistent, non- intrusive 
efforts were used to complete post- intervention and 
follow- up data collection. Participants were reimbursed 
£10 per hour for data completion at each point.
Analysis
Statistical analysis was mainly descriptive using means and 
SD for continuous data, or medians and range where data 
were skewed. Frequencies and proportions were used to 
describe categorical variables. Feasibility of trial retention 
was assessed using the proportion of a predetermined 
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parameter and estimated 95% CIs. Clinical outcomes 
were analysed using analysis of covariance models to 
estimate likely range of intervention effect, by assessing 
95% CI, at post- treatment, with pre- randomisation values 
as a covariate.58 Follow- up data were not included in 
these analyses due to a smaller sample than planned. 
Standardised effect sizes were calculated using Cohen’s 
d. Given the complexity of coexistent parent and child 
mental health difficulties, the smallest change in outcome 
identified as clinically important is equivalent to a small 
effect size. Population variances for future power calcula-
tions were determined using the upper 80th percentile of 
CIs around the estimated population variance.58
Patient and public involvement
A senior staff member of a national service user organ-
isation was a co- applicant and contributed to research 
conception, planning and governance. A service user 
researcher was involved in the analysis, interpretation and 
dissemination of findings. A service user panel advised on 
trial planning, intervention methods, outcome selection 
and interpretation of findings.59
Independent nhs research and development approval
Research and development approvals were obtained from 
South London and Maudsley NHS Foundation Trust and 
Central and North- West London NHS Foundation Trust.
serious adverse events
The chief investigator was responsible for reporting 
serious adverse events to the trial’s independent Data 
Monitoring and Ethics Committee and responsible 
research ethics committee. No serious adverse events 
were reported.
results
Feasibility evaluation
Recruitment took 4 months longer than planned due 
to delays in Site 2, resulting in a revised sample size of 
48. Obtaining keyworker information on service users 
approached about trial participation proved impractical.
All referred service users (n=89, 100.0%) consented 
to research contact (see figure 1). Adult mental health 
services (AMHS) referred 30 (33.7%) parents, child and 
adolescent mental health services (CAMHS) 29 (32.6%) 
and children’s social care (CSS) 30 (33.7%). Site 1 
referred 65 (73.0%) parents. Researchers made contact 
with 87 (97.7%) parents, requiring 1 to 13 communica-
tions per participant.
Sixty (69.7%) parents met initial criteria and completed 
screening. The most common reason for ineligibility was 
parents declining trial participation (n=12, 13.5%). Six 
parents were excluded due to child- related reasons, most 
commonly presence of child developmental disorder.
Forty- eight consenting participants met parent and 
child screening criteria, all of whom completed baseline 
measures, representing 80.0% of screened parents, 53.9% 
of referred parents and 68.8% of the planned sample. Five 
(8.3%) met neither parent nor child screening criteria, 
four (6.7%) did not meet SAPAS criterion and three 
(5.0%) did not meet Strengths and Difficulties Question-
naire (SDQ) criterion.
Thirty- six (75.0%) participants were from Site 1, 
exceeding the site recruitment target. Site 2 recruitment 
(n=12) was 34.3% of that planned, due to delayed recruit-
ment and lower service engagement. Eighteen (37.5%) 
participants were referred by AMHS, 16 (33.3%) CAMHS 
and 14 (29.2%) CSS.
There was a significant difference in trial condition 
uptake (HFP- M: n=21, 87.5%; Usual care n=15, 62.5%; 
χ2=4.0, df=1 (48), p<0.05). Modal duration between 
randomisation and starting HFP- M was 2 weeks (range 
1 to 23 weeks). Parents declined HFP- M because one 
gave birth, another was in couple conflict about partici-
pation and a third did not respond to persistent contact 
(see figure 1). The modal duration before Usual care 
parenting session receipt was 5.5 weeks (range 1 to 17 
weeks). The most common reason for declining the addi-
tional Usual care parenting session was that participants 
hoped to be allocated to HFP- M.
Thirty- two (66.7%, 95% CI 51.6% to 79.6%) partic-
ipants completed post- intervention measures. The 
majority of participants who did not take up the interven-
tion offered, mainly in the Usual care condition, did not 
complete post- intervention measures.
Twenty- one (65.6%) parents completing post- 
intervention measures were also assessed at follow- up, 
representing 43.8% of all participants. Post- intervention 
measures were completed a mean of 42.0 weeks (SD 14.6) 
after baseline, due to HFP- M delivery being lengthier 
in duration than planned. Follow- up measures were 
completed a mean of 20 weeks (SD 8.9) later. Researchers 
required one to eight participant contacts to arrange 
post- intervention and follow- up data collection. Main 
reasons for non- completion included unable to contact 
participant, participant declining completion and partici-
pant health and life circumstances.
There were less than 0.1% missing data items across 
clinical measures at each time point.
sample characteristics
Demographic characteristics
All 48 participants were the biological parent of the index 
child, one was a father (2.1%) (see table 1). The majority 
were lone parents (n=31, 67.4%), mean age 34.9 (SD 7.1) 
years. The majority (n=28, 61.0%) were White British/
White, with fewer Black/Black British (n=9, 19.6%) and 
Dual Heritage (n=6, 13.5%) parents. English was the most 
common first language (n=44, 91.7%). Twenty- five (55.6%) 
participants completed education at 18 years or younger. 
Four participants (8.9%) were higher education graduates.
Most participants (n=37, 80.4%) were not in paid employ-
ment. Nine (19.5%) had partners in paid employment, 
predominantly part- time (n=7, 15.2%). No parent was in 
paid employment in 30 (65.2%) households. Twenty- five 
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Figure 1 Consolidated Standards of Reporting Trials diagram randomised feasibility trial recruitment and retention. HFP- M, 
Helping FamiliesProgramme- Modified; UC, usual care.
(86.2%) parents had received a formal psychiatric diag-
nosis, mean time since initial diagnosis was 9.7 (7.4) years.
Twenty- six (54.2%) children were male, mean age of 7.8 
(SD 2.2) years. Median number of children in the home 
was 2, range 1 to 5 (see table 1). Participants reported signif-
icant difficulties with anxiety/depression, pain/discom-
fort, with a smaller proportion experiencing difficulties in 
undertaking everyday activities (see table 1).
Clinical characteristics
Over 80 per cent of ECBI Problem and Intensity scores 
at baseline exceeded the clinical caseness cut- off, with 
similar caseness rates for CBCL- Int and PS (see table 2). 
The most common baseline CAMC child- related parent 
concerns were conduct, self- regulation, parent- child rela-
tionships and emotional distress (see table 3).
trial interventions acceptability
HFP-M attendance
Of 21 participants who accepted HFP- M, 13 (61.9%, 
95% CI 38.4% to 81.9%) completed HFP- M within the 
trial period. Six (28.6%, 95% CI 11.3% to 52.2%) with-
drew before completion due to acute adult mental health 
crisis and complex family circumstances unrelated to 
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Table 2 Participant baseline clinical caseness
Measure
Baseline
Total Intervention Usual care
ECBI problem caseness (≥15) (n, %) 41 (89.1) 21 (87.5) 20 (90.9)
ECBI intensity caseness (≥131) (n, %) 39 (83.0) 19 (79.2) 20 (83.3)
CBCL- Int (t- score) caseness (≥60) (n, %) 45 (95.8) 23 (95.8) 22 (95.7)
PS caseness (≥3.2) (n, %) 35 (74.5) 18 (75.0) 17 (73.9)
CBCL- Int, Child Behaviour Checklist- Internalising Scale; ECBI, Eyberg Child Behaviour Inventory; PS, Arnold- O’Leary Parenting Scale.
Table 1 Participant demographic characteristics
Demographic characteristics
Baseline (Time 1)
Total Intervention Usual care
Parent gender (female) (n, %) 47 (97.9) 24 (100.0) 23 (95.8)
Parent age (yrs.) (mean, SD) 34.9 (7.1) 34.7 (7.5) 35.0 (6.9)
Received psychiatric diagnosis (n, %) 25 (86.2) 16 (88.9) 9 (81.8)
Psychiatric diagnosis duration (yrs.) (mean, SD) 9.7 (7.4) 8.6 (7.0) 10.9 (8.1)
Parent relationship to index child (biological parent) (n, %) 46 (100.0) 24 (100.0) 22 (100.0)
Index child gender (male) (n, %) 26 (55.3) 12 (50.0) 14 (60.9)
Index child age (mean, SD) 7.8 (2.2) 7.7 (2.0) 7.9 (2.2)
Number of children at home (median, range) 2 (1–5) 2 (1–5) 2 (1–5)
Not in paid employment (n, %) 37 (80.4) 19 (79.2) 18 (81.8)
Lone parent (n, %) 31 (67.4) 14 (58.3) 17 (77.3)
Partner in employment (n, %) 9 (19.5) 6 (25.0) 3 (12.5)
Parent education (n, %)
  Graduate 4 (8.9) 2 (8.3) 2 (9.5)
  University not completed 3 (6.7) 3 (12.5) 0 (0.0)
  Other for example, NVQ 13 (28.9) 6 (25.0) 7 (33.3)
  Left school 18 years 9 (20.0) 4 (16.7) 5 (23.8)
  Left school 16 years 7 (15.6) 4 (16.7) 3 (14.3)
  Left school under 16 9 (20.0) 5 (20.9) 4 (19.0)
Ethnicity (n, %)
  White UK/White other 28 (61.0) 13 (54.2) 15 (68.2)
  Black UK/African Caribbean 9 (19.6) 7 (29.2) 2 (9.1)
  Dual heritage 6 (13.0) 3 (12.5) 3 (13.6)
  Black UK/African 2 (4.3) 0 (0.0) 2 (9.1)
  Other 1 (2.2) 1 (4.2) 0 (0.0)
Parent health status* (n, %)
  Mobility problems 9 (25.0) 4 (23.5) 5 (26.4)
  Problems in self- care washing and dressing 3 (8.3) 1 (5.9) 2 (10.5)
  Difficulties in undertaking usual activities 13 (36.1) 7 (41.1) 6 (31.6)
  Suffered pain/discomfort 17 (47.2) 6 (35.3) 11 (57.9)
*EQ- 5D- 5L health moderate/severe status.
NVQ, National Vocational Qualification; yrs., years.
HFP- M receipt. Recruitment delay and longer than 
anticipated intervention duration resulted in two (9.5%, 
95% CI. 1.2% to 30.4%) participants not fully completing 
HFP- M before trial conclusion. The mean number of 
HFP- M appointments offered was 15.8 (SD 7.7) and mean 
number attended was 11.2 (SD 6.3). HFP- M appointment 
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Table 3 Parent- reported concerns about index child
Concern category Primary Secondary Tertiary Total
Conduct problems* (n, %) 18 (38.3) 27 (58.7) 24 (53.3) 69 (50.0)
Parent- child relationship and communication (n, %) 16 (34.0) 2 (4.4) 4 (8.9) 22 (15.9)
Child self- regulation† (n, %) 4 (8.5) 11 (23.9) 7 (15.6) 22 (15.9)
Emotional distress‡ (n, %) 8 (17.0) 4 (8.8) 7 (15.6) 19 (13.8)
Other§ (n, %) 1 (2.1) 2 (4.4) 1 (2.2) 4 (2.9)
School (n, %) 0 (0.0) 0 (0.0) 2 (4.4) 2 (1.5)
Total (n, %) 47 46 45 138
*including anger, tantrums, defiance, non- compliance, aggression, running away and lying.
†including overactivity, poor concentration, overeating and wetting.
‡including low mood, anxiety, low self- esteem.
§including risk behaviours.
attendance was 70.2%. Mean duration of HFP- M delivery 
was 28.4 (SD 21.7) weeks.
HFP-M therapeutic alliance acceptability
Eighteen (85.3%) HFP- M participants completed post- 
intervention WAI- SR (mean total score=73.8, SD 10.4). 
Mean subscale scores were consistently in the upper 
end of the scale (Mean Tasks Subscale score=24.9, SD 
3.5; Bond Subscale score=24.9, SD 3.9; Goals Subscale 
score=23.9, SD 4.1).
Usual care
All 15 participants accepting the additional parenting 
session completed. Due to lower retention, only six partic-
ipants provided post- intervention WAI- SR data (mean 
total score=56.2, SD 18.8). Mean subscales scores were 
consistently lower than the HFP- M condition (Mean Tasks 
Subscale score=17.4, SD 7.2; Bond Subscale score=19.8, 
SD 7.1; Goals Subscale score=19.0, SD 7.6).
There appeared to be a substantial difference in WAI- SR 
scores between the two conditions but there was insuffi-
cient Usual care data to test for a statistical difference.
No adverse events were reported during the trial. Partic-
ipant intervention withdrawal most frequently occurred 
due to deterioration in participant mental health and life 
circumstances, unrelated to trial participation.
Clinical outcomes
There were estimated mean improvements from base-
line scores across a number of outcomes within both 
trial conditions (see table 4). HFP- M mean differences 
exceeded those in Usual care on several outcomes. These 
findings should be treated with caution given the wide 
CIs.
Estimated effect sizes showed a general post- 
intervention advantage for HFP- M on a range of 
outcomes. Medium effects for child behavioural problem 
severity (ECBI Intensity, effect size (ES) 0.4, CI −0.3 to 
1.1), and parenting satisfaction (KPSS, ES 0.4, CI −0.3 to 
1.1) were detected and a large effect for parent- reported 
reductions in concerns about their child (CAMC Problem 
1, ES 1.2, CI 0.4 to 2.0, CAMC Problem 2, ES 1.3, CI 0.5 
to 2.1). No effects were detected for parenting behaviour 
and adult mental health. Descriptive scrutiny of follow- up 
findings showed that outcome scores across both groups 
were generally maintained or continued to improve.
Estimates of SD and upper CIs (u80% CI) for future 
power calculations of main clinical outcomes are: ECBI 
Problem: SD 6.7 (u80% CI: 7.6), ECBI Intensity: SD 33.6 
(u80% CI: 37.1), CAMC Problem 1: SD 15.3 (u80% CI: 
17.4) and KPSS: 3.0 (u80% CI: 3.3).
health economic findings
Details of the health economic analyses are provided in 
full in Day et al. At Time 2 CSRI data were available for 26 
cases and 19 cases at Time 3. CSRI Time 2 data revealed 
that the services most used by caregivers included general 
practitioners (GPs), psychiatrists, other medics and social 
workers. Caregivers were often in receipt of medication. 
Children were frequently in contact with school nurses, 
dentists, opticians and GPs. EQ- 5D- 5L data were available 
for 36 caregivers at Time 1, 32 at Time 2 and 21 at Time 
3. EQ- 5D- Y data were available for 38, 31 and 20 children 
at each of the respective time points.
COnClusIOn
This study assessed feasibility, potential challenges and 
decision- making for a definitive HFP- M trial.28–30 39 Partic-
ipant identification methods were successful across a 
wide range of mental health and CSS teams, over 90% 
of referred parents met dual child and parent screening 
criteria. Non- diagnostic eligibility criteria were accept-
able and effective in recruiting an appropriate, multi-
morbid sample.60 61 Negative life events and disrupted 
family functioning, characteristic of the sample popula-
tion, commonly delayed screening, data collection and 
intervention delivery.7 Nevertheless, participant reten-
tion exceeded the a priori primary feasibility criterion of 
65%. Participants declining intervention conditions were 
less likely to be retained at follow- up. Participant recruit-
ment was slower than planned, mainly due to operational 
difficulties in one site.
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Table 4 Parent reported child, parenting and parent clinical outcomes (intention to treat analysis)
Measure Group
Baseline
mean (SD)
(n)
Post- intervention
mean (SD)
(n)
Follow- up
mean (SD)
(n)
Baseline/post- intervention 
estimated mean difference (CI) P value Effect size
CAMC
  Problem 1 Intervention 84.6 (16.0)
(n=24)
45.2 (27.2)
(n=18)
58.2 (29.5)
(n=13)
18.633
(-40.177 to 2.910)
0.087 1.2
(0.4–2.0)
Usual care 85.9 (14.7)
(n=22)
63.1 (31.1)
(n=14)
53.3 (34.4)
(n=8)
  Problem 2 Intervention 85.0 (19.1)
(n=24)
51.1 (31.9)
(n=18)
56.4 (35.5)
(n=13)
22.486
(−44.318 to −0.654)
0.044 1.3
(0.5–2.1)
Usual care 82.9 (15.7)
(n=22)
72.5 (26.0)
(n=14)
66.5 (35.5)
(n=8)
  Problem 3 Intervention 81.0 (17.0)
(n=24)
54.4 (33.8)
(n=17)
42.8 (35.4)
(n=13)
2.909
(-28.349 to 22.530)
0.816 0.0
(-0.7–0.7)
Usual care 78.9 (18.5)
(n=22)
57.3 (34.1)
(n=14)
39.6 (24.3)
(n=8)
ECBI
  Problem 
score
Intervention 22.1 (7.4)
(n=24)
17.9 (8.5)
(n=15)
15.3 (9.4)
(n=13)
1.559
(−4.24=55 to 7.374)
0.585 0.1
(-0.7–0.88)
Usual care 22.43 (6.2)
(n=21)
18.0 (11.5)
(n=14)
18.8 (12.3)
(n=8)
  Intensity 
score
Intervention 168.2 (35.9)
(n=24)
142.4 (39.3)
(n=24)
131.7 (43.0)
(n=18)
12.866
(−4.24=55 to 7.374)
0.233 0.4
(-0.3–1.1)
Usual care 169.5 (31.8)
(n=23)
155.7 (49.6)
(n=14)
148.9 (58.4)
(n=8)
CBCL- Int
(t- score)
Intervention 72.9 (9.7)
(n=24)
69.6 (10.4)
(n=18)
68.2 (8.3)
(n=13)
1.853
(-9.023 to 5.317)
0.601 0.2
(-0.5–0.9)
Usual care 70.9 (11.9)
(n=23)
70.9 (9.3)
(n=14)
69.6 (8.6)
(n=8)
KPSS Intervention 10.1 (3.1)
(n=24)
12.9 (3.5)
(n=18)
14.9 (3.8)
(n=13)
1.177
(-1.260 to 3.615)
0.331 0.4
(-0.3–1.1)
Usual care 10.9 (2.8)
(n=23)
12.4 (3.9)
(n=14)
13.6 (3.9)
(n=7)
PS Intervention 111.0 (19.6)
(n=24)
108.7 (16.5)
(n=18)
98.3 (27.2)
(n=13)
0.210
(-14.776 to −15.196)
0.977 0.0
(-0.7–0.7)
Usual care 113.5 (24.8)
(n=23)
108.7 (28.9)
(n=14)
98.1 (26.9)
(n=7)
SCL-27 Global 
Severity Index
Intervention 1.8 (1.1)
(n=24
1.6 (0.8)
(n=18)
1.9 (0.8)
(n=13)
−0.105
(−0.599 to 0.389)
0.666 −0.1
(-0.8–0.6)
Usual care 1.7 (0.8)
(n=22)
1.7 (0.9)
(n=14)
1.3 (1.0)
(n=8)
CAMC, Concerns About My Child; CBCL- Int, Child Behaviour Checklist- Internalising Scale; ECBI, Eyberg Child Behaviour Inventory; KPSS, Kansas Parental 
Satisfaction Scale; PS, Arnold- O’Leary Parenting Scale; SCL-27, Symptom-Checklist-27.
Participants’ multimorbid characteristics are commonly 
associated with poorer treatment engagement and 
outcomes.62 63 Intervention uptake differed substantially 
between trial conditions. HFP- M was largely acceptable to 
participants but delivery was less efficient than planned, 
often due to parents’ life circumstances. The augmented 
Usual care condition appeared to be less acceptable, 
and potentially affected participant retention. Lower 
Usual care retention and acceptability rates may reflect 
common dissatisfaction associated with control condition 
allocation.64 65
Clinical effects were detected across trial conditions, 
with potential advantage for child behaviour, parental 
child concerns and parenting satisfaction for HFP- M. 
These are welcome given the population’s complex 
parenting impairments and negative treatment expectan-
cies.2 63 The final sample size limited trial power and conse-
quently affected interpretation of results. A definitive trial 
could potentially narrow child selection criteria to include 
only behaviour problems as parenting programmes have 
a stronger evidence base for this condition. Alternatively, 
HFP- M content may require strengthening specifically in 
relation to child internalising difficulties. Economic find-
ings indicated potential cost advantages for HFP- M over 
usual care.43 However, CSRI completion rates were not 
high and a simpler version may be required in a larger 
trial.
10 Day C, et al. BMJ Open 2020;10:e033637. doi:10.1136/bmjopen-2019-033637
Open access 
Trial conditions may have differed in duration, loca-
tion and therapeutic intensity, potentially accounting for 
outcome and acceptability differences. Data collection 
relied on parent self- report, which is conventional given 
poor reliability of child- report across the age group and 
costs associated with independent ratings. Trial therapists 
provided self- report intervention fidelity data and super-
vision examined therapist HFP- M skills and implementa-
tion. Independent methods could strengthen validity of 
fidelity monitoring in a definitive trial, including observa-
tional and video methods.
A definitive trial is potentially feasible and should be 
based on the assumption of a medium effect size for the 
primary outcome of child behaviour. Site engagement, 
resource allocation and keyworker training in partici-
pant identification and recruitment will be crucial to 
enrolment of the larger sample required in a future trial. 
Embedded researchers assisting in caseload identifica-
tion and direct parent recruitment, not possible in this 
feasibility study, may promote enrolment. Participant 
retention, particularly parents allocated to a usual care 
condition, will continue to be challenging for a full trial. 
The population’s complex personality difficulties and, 
typically, heightened sensitivity to rejection, underline 
the importance of managing sensitively and effectively 
trial consent procedures, the emotional and practical 
consequences of random allocation and proactively 
maintaining communication and validating relationships 
with participants throughout trial duration, particularly 
for those allocated to usual care. Though not routinely 
available, the usual care condition could be augmented 
with an ongoing parent support group to potentially 
increase equipoise, face validity and uptake, which may 
also benefit trial retention.
HFP- M clinical and trial efficiency may be improved 
with more explicit, validating discussion with participants 
about the potential impact of life and personal circum-
stances on attendance, use of pre- emptive cancellation 
plans and inclusion of inter- session contact using digital 
technology.31 63 66
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